The development of neurotherapeutics is increasing, and, therefore, it is imperative that clinical trials keep pace with regard to improving enrollment, design, and outcomes.
This will be a topic for discussion at the 144th Annual Meeting of the American Neurological Association (ANA) in October 2019. Speaker Lindsay Alfano, DPT, PCS, answered our questions about her upcoming session.
Read the full interview here: 4 Questions About Designing Novel Functional Outcomes for Clinical Trials